Clinical trial
CIPAMI-Study: Clopidogrel Administered Prehospital to Improve Primary PCI in Patients With Acute Myocardial Infarction
NCT00372216 is registered in ClinicalTrials.gov with Stiftung Institut fuer Herzinfarktforschung as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- CIPAMI-Study: Clopidogrel Administered Prehospital to Improve Primary PCI in Patients With Acute Myocardial Infarction
- Lead sponsor
- Stiftung Institut fuer Herzinfarktforschung
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- October 31, 2006
- Completion date
- January 31, 2010
- Enrollment
- 337 (actual)
- Sites
- 25
Conditions
As the registry lists them; a condition with its own page is linked.